In8Bio (INAB) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
In8Bio (INAB) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 1.79 |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | -1.18 |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 0.05 |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.39 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 1.96 Bn | 1.79 Bn | 56.40 Mn | 0.04 |
| 10 | In8Bio | 21.41 Mn | 21.41 Mn | - | -0.24 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.24 |
| Mar 31, 2026 | -0.25 |
| Dec 31, 2025 | -1.11 |
| Sep 30, 2025 | -0.82 |
| Jun 30, 2025 | -1.21 |
| Mar 31, 2025 | -1.96 |
| Dec 31, 2024 | -3.42 |
| Sep 30, 2024 | -4.48 |
| Jun 30, 2024 | -5.70 |
| Mar 31, 2024 | -5.88 |
| Dec 31, 2023 | -7.63 |
| Sep 30, 2023 | -6.82 |
| Jun 30, 2023 | -8.13 |
| Mar 31, 2023 | -9.13 |
| Dec 31, 2022 | -11.16 |
| Sep 30, 2022 | -10.25 |
| Jun 30, 2022 | -11.44 |
| Mar 31, 2022 | -9.81 |
| Dec 31, 2021 | -17.60 |
| Sep 30, 2021 | -7.61 |